[1]
Czarkowski, M., Raksa, K., Powroźniak, E. and Spozowski, K. 2022. Impact of SGLT2 inhibitors treatment on the chronic kidney disease in people with type 2 diabetes. Journal of Education, Health and Sport. 12, 9 (Sep. 2022), 319–327. DOI:https://doi.org/10.12775/JEHS.2022.12.09.036.